Ana Gonzalez-Corpas
Overview
Explore the profile of Ana Gonzalez-Corpas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Orea M, Angulo J, Gonzalez-Corpas A, Echegaray D, Marva M, Lobo M, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36614243
Castration-resistant prostate cancer (CRPC) development is the foremost concern after treatment of patients with high risk with locally advanced or metastatic prostate cancer. Androgen receptor (AR) is the main driver...
2.
Serna M, Gonzalez-Corpas A, Cabezudo S, Lopez-Perrote A, Degliesposti G, Zarzuela E, et al.
Nucleic Acids Res
. 2021 Dec;
50(2):1128-1146.
PMID: 34951455
Biogenesis of the U5 small nuclear ribonucleoprotein (snRNP) is an essential and highly regulated process. In particular, PRPF8, one of U5 snRNP main components, requires HSP90 working in concert with...
3.
Del Fresno C, Garcia-Arriaza J, Martinez-Cano S, Heras-Murillo I, Jarit-Cabanillas A, Amores-Iniesta J, et al.
Front Immunol
. 2021 Dec;
12:748103.
PMID: 34867974
COVID-19-specific vaccines are efficient prophylactic weapons against SARS-CoV-2 virus. However, boosting innate responses may represent an innovative way to immediately fight future emerging viral infections or boost vaccines. MV130 is...
4.
Lopez-Perrote A, Hug N, Gonzalez-Corpas A, Rodriguez C, Serna M, Garcia-Martin C, et al.
Elife
. 2020 Nov;
9.
PMID: 33205750
Nonsense-mediated mRNA decay (NMD) is a surveillance pathway that degrades aberrant mRNAs and also regulates the expression of a wide range of physiological transcripts. RUVBL1 and RUVBL2 AAA-ATPases form an...
5.
Ashour N, Angulo J, Gonzalez-Corpas A, Orea M, Lobo M, Colomer R, et al.
Int J Mol Sci
. 2020 Jul;
21(13).
PMID: 32630147
Prostate and breast cancer constitute the most common cancers among men and women worldwide. The aging population is one of the main risk factors for prostate and breast cancer development...
6.
Garcia-Carpizo V, Ruiz-Llorente S, Sarmentero J, Gonzalez-Corpas A, Barrero M
Mol Cancer Res
. 2019 Jan;
17(3):720-730.
PMID: 30606771
Inhibitors that prevent the binding of bromodomains to acetylated histones hold therapeutic potential. However, the effects of targeting most of the 60 different bromodomains found in the human proteome remain...
7.
Lopez J, Angulo J, Martin A, Sanchez-Chapado M, Gonzalez-Corpas A, Colas B, et al.
APMIS
. 2017 Jun;
125(9):787-796.
PMID: 28586118
DNA hypermethylation has emerged as a molecular biomarker for the evaluation of cancer diagnosis and prognosis. We define a methylation signature of bladder cancer and evaluate whether this profile assesses...
8.
Alelu-Paz R, Carmona F, Sanchez-Mut J, Cariaga-Martinez A, Gonzalez-Corpas A, Ashour N, et al.
Front Psychol
. 2016 Oct;
7:1496.
PMID: 27746755
Attempts to discover genes that are involved in the pathogenesis of major psychiatric disorders have been frustrating and often fruitless. Concern is building about the need to understand the complex...
9.
Alelu-Paz R, Gonzalez-Corpas A, Ashour N, Escanilla A, Monje A, Marquez C, et al.
Int J Geriatr Psychiatry
. 2014 Jul;
30(6):558-65.
PMID: 25044034
Objective: To analyze, in older patients with schizophrenia, the methylation status of a set of genes associated with the pathophysiology of the disorder but including anatomical, clinical, and cognitive criteria...
10.
Ashour N, Angulo J, Andres G, Alelu R, Gonzalez-Corpas A, Toledo M, et al.
Prostate
. 2014 Jun;
74(12):1171-82.
PMID: 24961912
Background: DNA hypermethylation has emerged as a novel molecular biomarker for the evaluation of prostate cancer diagnosis and prognosis. Defining the specific gene hypermethylation profile for prostate cancer could involve...